OverviewSuggest Edit

Mercurna is a biotech company delivering messenger RNA (mRNA) based medicines. It offers a platform technology that combines cell-targeting ligands with a proprietary lipid-based delivery vehicle in order to deliver engineered mRNA to the diseased tissues. The company specializes in providing precision medicines for eye disease, gum disease, chronic kidney disease, sepsis, and skin and lung diseases.

Recent NewsAll News

Latest Updates

Employees (est.) (Nov 2021)4
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Mercurna

Roland Brock

Roland Brock


Mercurna Financials and Metrics

Summary Metrics

Founding Date


Mercurna total Funding

$81.1 k

Mercurna latest funding size

$81.09 k

Time since last funding

3 years ago

Mercurna investors

Mercurna's latest funding round in December 2018 was reported to be $81.1 k. In total, Mercurna has raised $81.1 k
Show all financial metrics

Mercurna Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Mercurna Online and Social Media Presence

Embed Graph

Mercurna Blogs

Mercurna welcomes a new team member

On the 29th of August 2020, the Mercurna team welcomed a new member: Sander Keij. Sander is a highly motivated student and has already impressed as a fast learner. He

Mercurna Frequently Asked Questions

  • When was Mercurna founded?

    Mercurna was founded in 2017.

  • Who are Mercurna key executives?

    Mercurna's key executives are Roland Brock.

  • How many employees does Mercurna have?

    Mercurna has 4 employees.

  • Who are Mercurna competitors?

    Competitors of Mercurna include RNACure, Stemirna and ProLynx.